Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | CA6 | P23280 | 1/20 | 0.43 |
| ▸ | CA5A | P35218 | 1/20 | 0.43 |
| ▸ | CA7 | P43166 | 1/20 | 0.43 |
| ▸ | CA9 | Q16790 | 1/20 | 0.43 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | IDO1 | P14902 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3878150 | 0.80 | KDM4E (0.33) | TDP1ALDH1A1L3MBTL1LMNACYP1A2 | |
| SCHEMBL244118 | 0.76 | KDM4E (0.43) | TDP1ALDH1A1L3MBTL1POLBLMNA | |
| SCHEMBL1781557 | 0.76 | KDM4E (0.52) | CA12CA1CA2CA9ALDH1A1 | |
| Hydrochloric Acid SCHEMBL31549660 | 0.74 | KDM4E (0.50) | CA12CA1CA2CA9TDP1 | |
| Bromide SCHEMBL20984459 | 0.74 | KDM4E (0.50) | CA12CA1CA2CA9ALDH1A1 | |
| Hydrochloric Acid SCHEMBL1821629 | 0.74 | KDM4E (0.50) | CA12CA1CA2CA9TDP1 | |
| Hydrochloric Acid SCHEMBL28768961 | 0.74 | TDP1 (0.47) | CA12CA1CA2CA6CA5A | |
| SCHEMBL6300024 | 0.73 | TSHR (0.44) | ALDH1A1L3MBTL1LMNAGAAKDM4E | |
| SCHEMBL96064 | 0.73 | MAPT (0.50) | TDP1ALDH1A1L3MBTL1LMNACYP1A2 | |
| SCHEMBL5358661 | 0.73 | GAA (0.39) | CA12CA1CA2CA9ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4100007-A1 | ELONGATION FACTOR 1-ALPHA INHIBITORS AND USES THEREOF | The Regents of the University of California (US) | 2022-12-14 | — | — | EP | claimed |
| WO-2021158899-A1 | ELONGATION FACTOR 1-ALPHA INHIBITORS AND USES THEREOF | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2021-08-12 | — | — | WO | claimed |
| EP-4370528-A1 | AQUEOUS SOLID PHASE PEPTIDE SYNTHESIS | Polypeptide Laboratories Holding (PPL) AB (SE) | 2024-05-22 | — | — | EP | disclosed |
| CN-117897392-A | Aqueous solid phase peptide synthesis | 多肽实验室(PPL)控股公司 | 2024-04-16 | — | — | CN | disclosed |
| US-20230135758-A1 | ELONGATION FACTOR 1-ALPHA INHIBITORS AND USES THEREOF | UNIV CALIFORNIA (US) | 2023-05-04 | — | — | US | disclosed |
| US-20230107647-A1 | SINGLE MOLECULE PEPTIDE SEQUENCING | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2023-04-06 | — | — | US | disclosed |
| WO-2023287345-A1 | AQUEOUS SOLID PHASE PEPTIDE SYNTHESIS | POLYPEPTIDE LABORATORIES HOLDING (PPL) AB (SE) | 2023-01-19 | — | — | WO | disclosed |
| EP-4100007-A1 | ELONGATION FACTOR 1-ALPHA INHIBITORS AND USES THEREOF | The Regents of the University of California (US) | 2022-12-14 | — | — | EP | disclosed |
| US-20220185841-A1 | METHOD FOR PRODUCING PEPTIDE COMPOUND, REAGENT FOR FORMING PROTECTIVE GROUP, AND HYDRAZINE DERIVATIVE | FUJIFILM CORPORATION (JP) | 2022-06-16 | — | — | US | disclosed |
| EP-4011902-A1 | METHOD FOR PRODUCING PEPTIDE COMPOUND, REAGENT FOR FORMING PROTECTING GROUP, AND HYDRAZINE DERIVATIVE | FUJIFILM Corporation (JP) | 2022-06-15 | — | — | EP | disclosed |
| US-11162952-B2 | Single molecule peptide sequencing | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2021-11-02 | — | — | US | disclosed |
| EP-1910826-A2 | MICROSTRUCTURE AND MICRODOMAIN MICROARRAYS, METHODS OF MAKING AND USING THEREOF | Arizona Board of Regents, acting for and on behalf of Arizona State University (US) | 2008-04-16 | — | — | EP | disclosed |
| US-20080008649-A1 | Gastrin Releasing Peptide Compounds | BRACCO IMAGING S.P.A. (IT) | 2008-01-10 | — | — | US | disclosed |
| WO-2006138479-A2 | MICROSTRUCTURE AND MICRODOMAIN MICROARRAYS, METHODS OF MAKING AND USING THEREOF | ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2006-12-28 | — | — | WO | disclosed |
| US-20060018830-A1 | Gastrin releasing peptide compounds | BRACCO IMAGING S.P.A. (IT) | 2006-01-26 | — | — | US | disclosed |
| WO-2005118634-A2 | HELICAL PEPTIDOMIMETICS WITH ENHANCED ACTIVITY AGAINST BETA-AMYLOID PRODUCTION | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2005-12-15 | — | — | WO | disclosed |
| US-20050272659-A1 | Helical peptidomimetics with enhanced activity | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2005-12-08 | — | — | US | disclosed |
| WO-2005108992-A1 | MICROARRAY OF THREE-DIMENSIONAL HETEROPOLYMER MICROSTRUCTURES AND METHOD THEREFOR | ARIZONA BOARD OF REGENTS, ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2005-11-17 | — | — | WO | disclosed |
| WO-2003105751-A2 | NOVEL CURCUMIN DERIVATIVES | KWON HO-JEONG (KR) | 2003-12-24 | — | — | WO | disclosed |
| EP-0184363-A2 | Enzyme conjugates and their therapeutical use | BEECHAM GROUP PLC (GB) | 1986-06-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230107647-A1 | SINGLE MOLECULE PEPTIDE SEQUENCING | QPCTL, ANPEP, VIP | CA12 2991/4885CA1 2934/4885CA2 3496/4885 |
| US-20220185841-A1 | METHOD FOR PRODUCING PEPTIDE COMPOUND, REAGENT FOR FORMING PROTECTIVE GROUP, AND HYDRAZINE DERIVATIVE | VIP, HRH1, NGLY1 | CA12 873/4885CA1 267/4885CA2 2504/4885 |
| US-20080008649-A1 | Gastrin Releasing Peptide Compounds | GRPR, SSTR5, GIPR | CA12 207/4885CA1 301/4885CA2 377/4885 |
| US-20060018830-A1 | Gastrin releasing peptide compounds | GRPR, GIPR, CCKBR | CA12 267/4885CA1 294/4885CA2 742/4885 |
| US-11162952-B2 | Single molecule peptide sequencing | MICA, ANPEP, VIP | CA12 3473/4885CA1 4419/4885CA2 4388/4885 |
| US-20230135758-A1 | ELONGATION FACTOR 1-ALPHA INHIBITORS AND USES THEREOF | EEF1A1, EEF1B2, EEF1G | CA12 4879/4885CA1 4845/4885CA2 4843/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.